US28414H1032 - Common Stock
ELANCO ANIMAL HEALTH INC
NYSE:ELAN (3/28/2024, 8:06:49 PM)
After market: 16.28 0 (0%)16.28
+0.11 (+0.68%)
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana and currently employs 9,000 full-time employees. The company went IPO on 2018-09-20. The firm is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. The company offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its Farm Animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others.
ELANCO ANIMAL HEALTH INC
2500 Innovation Way N
Greenfield INDIANA 46140
P: 18773526261
CEO: Jeffrey N. Simmons
Employees: 9000
Website: https://www.elanco.com/
/PRNewswire/ -- Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O'Neill as the company's Executive Vice President, General Counsel...
Elanco's stock surges as Ancora Holdings reveals a 3% stake and pushes for CEO removal.
/PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today issued the following statement in response to the submission of four nominees to the...
Here you can normally see the latest stock twits on ELAN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: